Literature DB >> 19858458

"Frontotemporoparietal" dementia: clinical phenotype associated with the c.709-1G>A PGRN mutation.

F Moreno1, B Indakoetxea, M Barandiaran, A Alzualde, A Gabilondo, A Estanga, J Ruiz, M Ruibal, A Bergareche, J F Martí-Massó, A López de Munain.   

Abstract

BACKGROUND: Mutations in the progranulin gene (PGRN) are a major cause of frontotemporal lobar degeneration with tau-negative and ubiquitin-positive neuronal inclusions. Most previous studies aimed at characterizing the clinical and neuropsychological phenotype of PGRN mutation carriers included patients with different PGRN mutations, assuming that the common proposed pathogenetic mechanism of haploinsufficiency will lead to a comparable phenotype.
METHODS: We studied 21 patients with a single pathogenic splicing mutation in the PGRN gene (c.709-1G>A) in the same tertiary referral center using homogenous diagnostic criteria and protocols. All patients were of Basque descent.
RESULTS: Patients exhibited a variable phenotype both in age at onset and initial symptoms. Behavioral variant frontotemporal dementia (52.4%) and progressive nonfluent aphasia (23.8%) were the most common presenting syndromes. Apathy was the most common behavioral symptom. Patients developed a relatively rapidly progressive dementia with features that led to a secondary diagnosis in 61.9% of cases 2 years after primary diagnosis. Notably, this secondary or tertiary diagnosis was corticobasal syndrome in 47.6% of cases, which confirmed the neuropsychological features of parietal lobe dysfunction seen at the initial assessment in 81.8% of patients.
CONCLUSIONS: Patients carrying the c.709-1G>A mutation in the PGRN gene showed heterogeneous clinical and neuropsychological features and commonly developed corticobasal syndrome as the disease progressed.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19858458     DOI: 10.1212/WNL.0b013e3181bd82a7

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  13 in total

Review 1.  Advances in understanding the molecular basis of frontotemporal dementia.

Authors:  Rosa Rademakers; Manuela Neumann; Ian R Mackenzie
Journal:  Nat Rev Neurol       Date:  2012-06-26       Impact factor: 42.937

2.  Intra-familial clinical heterogeneity due to FTLD-U with TDP-43 proteinopathy caused by a novel deletion in progranulin gene (PGRN).

Authors:  Tomasz Gabryelewicz; Mario Masellis; Mariusz Berdynski; Juan M Bilbao; Ekaterina Rogaeva; Peter St George-Hyslop; Anna Barczak; Krzysztof Czyzewski; Maria Barcikowska; Zbigniew Wszolek; Sandra E Black; Cezary Zekanowski
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

3.  Prion protein codon 129 polymorphism modifies age at onset of frontotemporal dementia with the C.709-1G>A progranulin mutation.

Authors:  Fermín Moreno; Ainhoa Alzualde; Pablo Martínez Camblor; Myriam Barandiaran; Vivianna M Van Deerlin; Alazne Gabilondo; José F Martí Massó; Adolfo López de Munain; Begoña Indakoetxea
Journal:  Alzheimer Dis Assoc Disord       Date:  2011 Jan-Mar       Impact factor: 2.703

Review 4.  Parkinsonian syndrome in familial frontotemporal dementia.

Authors:  Joanna Siuda; Shinsuke Fujioka; Zbigniew K Wszolek
Journal:  Parkinsonism Relat Disord       Date:  2014-06-13       Impact factor: 4.891

Review 5.  Development of disease-modifying drugs for frontotemporal dementia spectrum disorders.

Authors:  Francesco Panza; Bruno P Imbimbo; Madia Lozupone; Davide Seripa; Antonio Daniele; Mark Watling; Gianluigi Giannelli
Journal:  Nat Rev Neurol       Date:  2020-03-23       Impact factor: 42.937

6.  Increased Wnt Signaling and Reduced Viability in a Neuronal Model of Progranulin-Deficient Frontotemporal Lobar Degeneration.

Authors:  Ana de la Encarnación; Carolina Alquézar; Ángeles Martín-Requero
Journal:  Mol Neurobiol       Date:  2015-12-17       Impact factor: 5.590

7.  Genetic screen in a large series of patients with primary progressive aphasia.

Authors:  Eliana Marisa Ramos; Deepika Reddy Dokuru; Victoria Van Berlo; Kevin Wojta; Qing Wang; Alden Y Huang; Zachary A Miller; Anna M Karydas; Eileen H Bigio; Emily Rogalski; Sandra Weintraub; Benjamin Rader; Bruce L Miller; Maria Luisa Gorno-Tempini; Marek-Marsel Mesulam; Giovanni Coppola
Journal:  Alzheimers Dement       Date:  2019-01-25       Impact factor: 21.566

Review 8.  Frontotemporal dementia: latest evidence and clinical implications.

Authors:  Juan Joseph Young; Mallika Lavakumar; Deena Tampi; Silpa Balachandran; Rajesh R Tampi
Journal:  Ther Adv Psychopharmacol       Date:  2017-11-10

9.  Progress in the last decade in our understanding of primary progressive aphasia.

Authors:  Ellajosyula Ratnavalli
Journal:  Ann Indian Acad Neurol       Date:  2010-12       Impact factor: 1.383

10.  Inactivation of CDK/pRb pathway normalizes survival pattern of lymphoblasts expressing the FTLD-progranulin mutation c.709-1G>A.

Authors:  Carolina Alquezar; Noemí Esteras; Ainhoa Alzualde; Fermín Moreno; Matilde S Ayuso; Adolfo López de Munain; Ángeles Martín-Requero
Journal:  PLoS One       Date:  2012-05-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.